Pre-order Enquiry
Request Free Sample
Global Recombinant Human Granulocyte Colony-Stimulating Market Research Report 2020
SKU ID : QYR-15124750 | Publishing Date : 24-Jan-2020 | No. of pages : 122
Detailed TOC of Global Recombinant Human Granulocyte Colony-Stimulating Market Research Report 2020
Table of Contents1 Recombinant Human Granulocyte Colony-Stimulating Market Overview
1.1 Product Overview and Scope of Recombinant Human Granulocyte Colony-Stimulating
1.2 Recombinant Human Granulocyte Colony-Stimulating Segment by Type
1.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Lenograstim (Granocyte)
1.2.3 Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim)
1.2.4 Others
1.3 Recombinant Human Granulocyte Colony-Stimulating Segment by Application
1.3.1 Recombinant Human Granulocyte Colony-Stimulating Sales Comparison by Application: 2020 VS 2026
1.3.2 Chemotherapy Induced Neutropenia
1.3.3 Before Blood Donation
1.3.4 Stem Cell Transplants
1.3.5 Others
1.4 Global Recombinant Human Granulocyte Colony-Stimulating Market Size Estimates and Forecasts
1.4.1 Global Recombinant Human Granulocyte Colony-Stimulating Revenue 2015-2026
1.4.2 Global Recombinant Human Granulocyte Colony-Stimulating Sales 2015-2026
1.4.3 Recombinant Human Granulocyte Colony-Stimulating Market Size by Region: 2020 Versus 2026
2 Global Recombinant Human Granulocyte Colony-Stimulating Market Competition by Manufacturers
2.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Manufacturers (2015-2020)
2.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue Share by Manufacturers (2015-2020)
2.3 Global Recombinant Human Granulocyte Colony-Stimulating Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Recombinant Human Granulocyte Colony-Stimulating Manufacturing Sites, Area Served, Product Type
2.5 Recombinant Human Granulocyte Colony-Stimulating Market Competitive Situation and Trends
2.5.1 Recombinant Human Granulocyte Colony-Stimulating Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Recombinant Human Granulocyte Colony-Stimulating Players (Opinion Leaders)
3 Recombinant Human Granulocyte Colony-Stimulating Retrospective Market Scenario by Region
3.1 Global Recombinant Human Granulocyte Colony-Stimulating Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Recombinant Human Granulocyte Colony-Stimulating Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Country
3.3.1 North America Recombinant Human Granulocyte Colony-Stimulating Sales by Country
3.3.2 North America Recombinant Human Granulocyte Colony-Stimulating Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Country
3.4.1 Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Country
3.4.2 Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Region
3.5.1 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales by Region
3.5.2 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Country
3.6.1 Latin America Recombinant Human Granulocyte Colony-Stimulating Sales by Country
3.6.2 Latin America Recombinant Human Granulocyte Colony-Stimulating Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Country
3.7.1 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales by Country
3.7.2 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Recombinant Human Granulocyte Colony-Stimulating Historic Market Analysis by Type
4.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2015-2020)
4.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Type (2015-2020)
4.3 Global Recombinant Human Granulocyte Colony-Stimulating Price Market Share by Type (2015-2020)
4.4 Global Recombinant Human Granulocyte Colony-Stimulating Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Recombinant Human Granulocyte Colony-Stimulating Historic Market Analysis by Application
5.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2015-2020)
5.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Application (2015-2020)
5.3 Global Recombinant Human Granulocyte Colony-Stimulating Price by Application (2015-2020)
6 Company Profiles and Key Figures in Recombinant Human Granulocyte Colony-Stimulating Business
6.1 Amgen
6.1.1 Corporation Information
6.1.2 Amgen Description, Business Overview and Total Revenue
6.1.3 Amgen Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Amgen Products Offered
6.1.5 Amgen Recent Development
6.2 Qilu Pharmaceutical
6.2.1 Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Production Sites and Area Served
6.2.2 Qilu Pharmaceutical Description, Business Overview and Total Revenue
6.2.3 Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Qilu Pharmaceutical Products Offered
6.2.5 Qilu Pharmaceutical Recent Development
6.3 Shijiazhuang Pharmaceutical
6.3.1 Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Production Sites and Area Served
6.3.2 Shijiazhuang Pharmaceutical Description, Business Overview and Total Revenue
6.3.3 Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Shijiazhuang Pharmaceutical Products Offered
6.3.5 Shijiazhuang Pharmaceutical Recent Development
6.4 Kyowa Hakko Kirin
6.4.1 Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Production Sites and Area Served
6.4.2 Kyowa Hakko Kirin Description, Business Overview and Total Revenue
6.4.3 Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Kyowa Hakko Kirin Products Offered
6.4.5 Kyowa Hakko Kirin Recent Development
6.5 Gensci
6.5.1 Gensci Recombinant Human Granulocyte Colony-Stimulating Production Sites and Area Served
6.5.2 Gensci Description, Business Overview and Total Revenue
6.5.3 Gensci Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Gensci Products Offered
6.5.5 Gensci Recent Development
6.6 Amoytop Biotech
6.6.1 Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Production Sites and Area Served
6.6.2 Amoytop Biotech Description, Business Overview and Total Revenue
6.6.3 Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Amoytop Biotech Products Offered
6.6.5 Amoytop Biotech Recent Development
6.7 Hangzhou Jiuyuan
6.6.1 Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Production Sites and Area Served
6.6.2 Hangzhou Jiuyuan Description, Business Overview and Total Revenue
6.6.3 Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Hangzhou Jiuyuan Products Offered
6.7.5 Hangzhou Jiuyuan Recent Development
6.8 Huaxin
6.8.1 Huaxin Recombinant Human Granulocyte Colony-Stimulating Production Sites and Area Served
6.8.2 Huaxin Description, Business Overview and Total Revenue
6.8.3 Huaxin Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Huaxin Products Offered
6.8.5 Huaxin Recent Development
6.9 Triprime
6.9.1 Triprime Recombinant Human Granulocyte Colony-Stimulating Production Sites and Area Served
6.9.2 Triprime Description, Business Overview and Total Revenue
6.9.3 Triprime Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Triprime Products Offered
6.9.5 Triprime Recent Development
6.10 Sinovac
6.10.1 Sinovac Recombinant Human Granulocyte Colony-Stimulating Production Sites and Area Served
6.10.2 Sinovac Description, Business Overview and Total Revenue
6.10.3 Sinovac Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Sinovac Products Offered
6.10.5 Sinovac Recent Development
6.11 Zhaoke
6.11.1 Zhaoke Recombinant Human Granulocyte Colony-Stimulating Production Sites and Area Served
6.11.2 Zhaoke Recombinant Human Granulocyte Colony-Stimulating Description, Business Overview and Total Revenue
6.11.3 Zhaoke Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Zhaoke Products Offered
6.11.5 Zhaoke Recent Development
6.12 Kawin
6.12.1 Kawin Recombinant Human Granulocyte Colony-Stimulating Production Sites and Area Served
6.12.2 Kawin Recombinant Human Granulocyte Colony-Stimulating Description, Business Overview and Total Revenue
6.12.3 Kawin Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Kawin Products Offered
6.12.5 Kawin Recent Development
7 Recombinant Human Granulocyte Colony-Stimulating Manufacturing Cost Analysis
7.1 Recombinant Human Granulocyte Colony-Stimulating Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Recombinant Human Granulocyte Colony-Stimulating
7.4 Recombinant Human Granulocyte Colony-Stimulating Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Recombinant Human Granulocyte Colony-Stimulating Distributors List
8.3 Recombinant Human Granulocyte Colony-Stimulating Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Recombinant Human Granulocyte Colony-Stimulating Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Recombinant Human Granulocyte Colony-Stimulating by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Recombinant Human Granulocyte Colony-Stimulating by Type (2021-2026)
10.2 Recombinant Human Granulocyte Colony-Stimulating Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Recombinant Human Granulocyte Colony-Stimulating by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Recombinant Human Granulocyte Colony-Stimulating by Application (2021-2026)
10.3 Recombinant Human Granulocyte Colony-Stimulating Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Recombinant Human Granulocyte Colony-Stimulating by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Recombinant Human Granulocyte Colony-Stimulating by Region (2021-2026)
10.4 North America Recombinant Human Granulocyte Colony-Stimulating Estimates and Projections (2021-2026)
10.5 Europe Recombinant Human Granulocyte Colony-Stimulating Estimates and Projections (2021-2026)
10.6 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Estimates and Projections (2021-2026)
10.7 Latin America Recombinant Human Granulocyte Colony-Stimulating Estimates and Projections (2021-2026)
10.8 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Figures, Tables and Charts Available in Global Recombinant Human Granulocyte Colony-Stimulating Market Research Report 2020
List of TablesTable 1. Global Recombinant Human Granulocyte Colony-Stimulating Sales (KG) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Recombinant Human Granulocyte Colony-Stimulating Sales (KG) Comparison by Application: 2020 VS 2026
Table 3. Global Recombinant Human Granulocyte Colony-Stimulating Market Size by Type (KG) (US$ Million) (2020 VS 2026)
Table 4. Global Key Recombinant Human Granulocyte Colony-Stimulating Manufacturers Covered in This Study
Table 5. Global Recombinant Human Granulocyte Colony-Stimulating Sales (KG) by Manufacturers (2015-2020)
Table 6. Global Recombinant Human Granulocyte Colony-Stimulating Sales Share by Manufacturers (2015-2020)
Table 7. Global Recombinant Human Granulocyte Colony-Stimulating Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Recombinant Human Granulocyte Colony-Stimulating Average Price (USD/g) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Recombinant Human Granulocyte Colony-Stimulating Sales Sites and Area Served
Table 11. Manufacturers Recombinant Human Granulocyte Colony-Stimulating Product Types
Table 12. Global Recombinant Human Granulocyte Colony-Stimulating Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Recombinant Human Granulocyte Colony-Stimulating by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Human Granulocyte Colony-Stimulating as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Recombinant Human Granulocyte Colony-Stimulating Players
Table 16. Global Recombinant Human Granulocyte Colony-Stimulating Sales (KG) by Region (2015-2020)
Table 17. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Region (2015-2020)
Table 18. Global Recombinant Human Granulocyte Colony-Stimulating Revenue (Million US$) by Region (2015-2020)
Table 19. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Region (2015-2020)
Table 20. North America Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2015-2020) (KG)
Table 21. North America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country (2015-2020)
Table 22. North America Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country (2015-2020)
Table 24. Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2015-2020) (KG)
Table 25. Europe Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country (2015-2020)
Table 26. Europe Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales by Region (2015-2020) (KG)
Table 29. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Region (2015-2020)
Table 32. Latin America Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2015-2020) (KG)
Table 33. Latin America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country (2015-2020)
Table 34. Latin America Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2015-2020) (KG)
Table 37. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country (2015-2020)
Table 40. Global Recombinant Human Granulocyte Colony-Stimulating Sales (KG) by Type (2015-2020)
Table 41. Global Recombinant Human Granulocyte Colony-Stimulating Sales Share by Type (2015-2020)
Table 42. Global Recombinant Human Granulocyte Colony-Stimulating Revenue (Million US$) by Type (2015-2020)
Table 43. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Share by Type (2015-2020)
Table 44. Global Recombinant Human Granulocyte Colony-Stimulating Price (USD/g) by Type (2015-2020)
Table 45. Global Recombinant Human Granulocyte Colony-Stimulating Sales (KG) by Application (2015-2020)
Table 46. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2015-2020)
Table 47. Global Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate by Application (2015-2020)
Table 48. Amgen Recombinant Human Granulocyte Colony-Stimulating Corporation Information
Table 49. Amgen Description and Business Overview
Table 50. Amgen Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 51. Amgen Main Product
Table 52. Amgen Recent Development
Table 53. Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Corporation Information
Table 54. Qilu Pharmaceutical Corporation Information
Table 55. Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 56. Qilu Pharmaceutical Main Product
Table 57. Qilu Pharmaceutical Recent Development
Table 58. Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Corporation Information
Table 59. Shijiazhuang Pharmaceutical Corporation Information
Table 60. Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 61. Shijiazhuang Pharmaceutical Main Product
Table 62. Shijiazhuang Pharmaceutical Recent Development
Table 63. Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Corporation Information
Table 64. Kyowa Hakko Kirin Corporation Information
Table 65. Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 66. Kyowa Hakko Kirin Main Product
Table 67. Kyowa Hakko Kirin Recent Development
Table 68. Gensci Recombinant Human Granulocyte Colony-Stimulating Corporation Information
Table 69. Gensci Corporation Information
Table 70. Gensci Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 71. Gensci Main Product
Table 72. Gensci Recent Development
Table 73. Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Corporation Information
Table 74. Amoytop Biotech Corporation Information
Table 75. Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 76. Amoytop Biotech Main Product
Table 77. Amoytop Biotech Recent Development
Table 78. Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Corporation Information
Table 79. Hangzhou Jiuyuan Corporation Information
Table 80. Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 81. Hangzhou Jiuyuan Main Product
Table 82. Hangzhou Jiuyuan Recent Development
Table 83. Huaxin Recombinant Human Granulocyte Colony-Stimulating Corporation Information
Table 84. Huaxin Corporation Information
Table 85. Huaxin Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 86. Huaxin Main Product
Table 87. Huaxin Recent Development
Table 88. Triprime Recombinant Human Granulocyte Colony-Stimulating Corporation Information
Table 89. Triprime Corporation Information
Table 90. Triprime Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 91. Triprime Main Product
Table 92. Triprime Recent Development
Table 93. Sinovac Recombinant Human Granulocyte Colony-Stimulating Corporation Information
Table 94. Sinovac Corporation Information
Table 95. Sinovac Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 96. Sinovac Main Product
Table 97. Sinovac Recent Development
Table 98. Zhaoke Recombinant Human Granulocyte Colony-Stimulating Corporation Information
Table 99. Zhaoke Corporation Information
Table 100. Zhaoke Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 101. Zhaoke Main Product
Table 102. Zhaoke Recent Development
Table 103. Kawin Recombinant Human Granulocyte Colony-Stimulating Corporation Information
Table 104. Kawin Corporation Information
Table 105. Kawin Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 106. Kawin Main Product
Table 107. Kawin Recent Development
Table 108. Sales Base and Market Concentration Rate of Raw Material
Table 109. Key Suppliers of Raw Materials
Table 110. Recombinant Human Granulocyte Colony-Stimulating Distributors List
Table 111. Recombinant Human Granulocyte Colony-Stimulating Customers List
Table 112. Market Key Trends
Table 113. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 114. Key Challenges
Table 115. Global Recombinant Human Granulocyte Colony-Stimulating Sales (KG) Forecast by Type (2021-2026)
Table 116. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share Forecast by Type (2021-2026)
Table 117. Global Recombinant Human Granulocyte Colony-Stimulating Revenue (Million US$) Forecast by Type (2021-2026)
Table 118. Global Recombinant Human Granulocyte Colony-Stimulating Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 119. Global Recombinant Human Granulocyte Colony-Stimulating Sales (KG) Forecast by Application (2021-2026)
Table 120. Global Recombinant Human Granulocyte Colony-Stimulating Revenue (Million US$) Forecast by Application (2021-2026)
Table 121. Global Recombinant Human Granulocyte Colony-Stimulating Sales (KG) Forecast by Region (2021-2026)
Table 122. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share Forecast by Region (2021-2026)
Table 123. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Region (2021-2026) (US$ Million)
Table 124. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share Forecast by Region (2021-2026)
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Recombinant Human Granulocyte Colony-Stimulating
Figure 2. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type: 2020 VS 2026
Figure 3. Lenograstim (Granocyte) Product Picture
Figure 4. Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim) Product Picture
Figure 5. Others Product Picture
Figure 6. Global Recombinant Human Granulocyte Colony-Stimulating Consumption Market Share by Application: 2020 VS 2026
Figure 7. Chemotherapy Induced Neutropenia
Figure 8. Before Blood Donation
Figure 9. Stem Cell Transplants
Figure 10. Others
Figure 11. Global Recombinant Human Granulocyte Colony-Stimulating Market Size 2015-2026 (US$ Million)
Figure 12. Global Recombinant Human Granulocyte Colony-Stimulating Sales Capacity (KG) (2015-2026)
Figure 13. Global Recombinant Human Granulocyte Colony-Stimulating Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Recombinant Human Granulocyte Colony-Stimulating Sales Share by Manufacturers in 2020
Figure 15. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Share by Manufacturers in 2019
Figure 16. The Global 5 and 10 Largest Players: Market Share by Recombinant Human Granulocyte Colony-Stimulating Revenue in 2019
Figure 17. Recombinant Human Granulocyte Colony-Stimulating Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 18. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Region (2015-2020)
Figure 19. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Region in 2019
Figure 20. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Region (2015-2020)
Figure 21. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Region in 2019
Figure 22. North America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country in 2019
Figure 23. North America Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country in 2019
Figure 24. U.S. Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 25. U.S. Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Canada Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 27. Canada Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 28. Europe Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country in 2019
Figure 29. Europe Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country in 2019
Figure 30. Germany Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 31. Germany Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. France Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 33. France Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. U.K. Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 35. U.K. Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Italy Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 37. Italy Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Russia Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 39. Russia Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Region in 2019
Figure 41. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Region in 2019
Figure 42. China Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 43. China Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Japan Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 45. Japan Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. South Korea Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 47. South Korea Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. India Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 49. India Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Australia Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 51. Australia Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Taiwan Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 53. Taiwan Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Indonesia Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 55. Indonesia Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Thailand Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 57. Thailand Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Malaysia Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 59. Malaysia Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Philippines Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 61. Philippines Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Vietnam Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 63. Vietnam Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Latin America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country in 2019
Figure 65. Latin America Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country in 2019
Figure 66. Mexico Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 67. Mexico Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Brazil Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 69. Brazil Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Argentina Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 71. Argentina Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country in 2019
Figure 73. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country in 2019
Figure 74. Turkey Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 75. Turkey Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Saudi Arabia Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 77. Saudi Arabia Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. U.A.E Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate (2015-2020) (KG)
Figure 79. U.A.E Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Sales Market Share of Recombinant Human Granulocyte Colony-Stimulating by Type (2015-2020)
Figure 81. Sales Market Share of Recombinant Human Granulocyte Colony-Stimulating by Type in 2019
Figure 82. Revenue Share of Recombinant Human Granulocyte Colony-Stimulating by Type (2015-2020)
Figure 83. Revenue Market Share of Recombinant Human Granulocyte Colony-Stimulating by Type in 2019
Figure 84. Global Recombinant Human Granulocyte Colony-Stimulating Sales Growth by Type (2015-2020) (KG)
Figure 85. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2015-2020)
Figure 86. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application in 2019
Figure 87. Global Revenue Share of Recombinant Human Granulocyte Colony-Stimulating by Application (2015-2020)
Figure 88. Global Revenue Share of Recombinant Human Granulocyte Colony-Stimulating by Application in 2020
Figure 89. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Qilu Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Shijiazhuang Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Kyowa Hakko Kirin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Gensci Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Amoytop Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Hangzhou Jiuyuan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Huaxin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Triprime Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Sinovac Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Zhaoke Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Kawin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. Price Trend of Key Raw Materials
Figure 102. Manufacturing Cost Structure of Recombinant Human Granulocyte Colony-Stimulating
Figure 103. Manufacturing Process Analysis of Recombinant Human Granulocyte Colony-Stimulating
Figure 104. Recombinant Human Granulocyte Colony-Stimulating Industrial Chain Analysis
Figure 105. Channels of Distribution
Figure 106. Distributors Profiles
Figure 107. Porter's Five Forces Analysis
Figure 108. North America Recombinant Human Granulocyte Colony-Stimulating Sales (KG) and Growth Rate Forecast (2021-2026)
Figure 109. North America Recombinant Human Granulocyte Colony-Stimulating Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 110. Europe Recombinant Human Granulocyte Colony-Stimulating Sales (KG) and Growth Rate Forecast (2021-2026)
Figure 111. Europe Recombinant Human Granulocyte Colony-Stimulating Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 112. Latin America Recombinant Human Granulocyte Colony-Stimulating Sales (KG) and Growth Rate Forecast (2021-2026)
Figure 113. Latin America Recombinant Human Granulocyte Colony-Stimulating Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 114. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales (KG) and Growth Rate Forecast (2021-2026)
Figure 115. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 116. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales (KG) and Growth Rate Forecast (2021-2026)
Figure 117. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 118. Bottom-up and Top-down Approaches for This Report
Figure 119. Data Triangulation
Figure 120. Key Executives Interviewed
Keyplayers in Global Recombinant Human Granulocyte Colony-Stimulating Market Research Report 2020
AmgenQilu Pharmaceutical
Shijiazhuang Pharmaceutical
Kyowa Hakko Kirin
Gensci
Amoytop Biotech
Hangzhou Jiuyuan
Huaxin
Triprime
Sinovac
Zhaoke
Kawin
Request Sample
Request Discount
